Paper · 20161833
HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.
Degorce F and 5 others. Curr Chem Genomics, 2009. Cited by 374 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications. Papers, record 20161833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20161833
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,965,760 | D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. | Anal Biochem | 2006 | https://conductscience.org/library/papers/16965760 | PubMed |
| 2 | 20,161,828 | Cellular Ser/Thr-kinase assays using generic peptide substrates. | Curr Chem Genomics | 2008 | https://conductscience.org/library/papers/20161828 | PubMed |
| 3 | 18,626,113 | HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity. | J Biomol Screen | 2008 | https://conductscience.org/library/papers/18626113 | PubMed |
| 4 | 12,419,336 | Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract. | Anal Biochem | 2002 | https://conductscience.org/library/papers/12419336 | PubMed |
| 5 | 10,838,427 | HTRF(R) Technology. | J Biomol Screen | 1999 | https://conductscience.org/library/papers/10838427 | PubMed |
| 6 | 20,161,824 | Development of a HTRF kinase assay for determination of Syk activity. | Curr Chem Genomics | 2008 | https://conductscience.org/library/papers/20161824 | PubMed |
| 7 | 18,212,126 | Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18212126 | PubMed |
| 8 | 10,539,989 | Application of homogeneous time-resolved fluorescence (HTRFTM) to monitor poly-ubiquitination of wild-type p53. | Comb Chem High Throughput Screen | 1999 | https://conductscience.org/library/papers/10539989 | PubMed |
| 9 | 17,913,892 | Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17913892 | PubMed |
| 10 | 18,267,118 | Identification and characterization of small-molecule inhibitors of Tie2 kinase. | FEBS Lett | 2008 | https://conductscience.org/library/papers/18267118 | PubMed |
1 to 10 of 70
See all 70 referencesCited by184
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 374 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,794,777 | Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794777 | PubMed |
| 42,768,037 | Mapping of dynamic allostery within p38 alpha kinase via network analyses and NMR spectroscopy. | Nat Commun | 2026 | https://conductscience.org/library/papers/42768037 | PubMed |
| 42,712,076 | A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42712076 | PubMed |
| 42,446,647 | Screening the Tox21 Compound Library for Chemicals That Stimulate the Adrenergic β1 Receptor. | Chem Res Toxicol | 2026 | https://conductscience.org/library/papers/42446647 | PubMed |
| 42,380,604 | Mechanisms that matter: unbiased cellular screening for degraders. | NPJ Drug Discov | 2025 | https://conductscience.org/library/papers/42380604 | PubMed |
| 42,347,521 | Biophysical and Biochemical Assays for Screening Small Molecule Inhibitors Targeting Toxin-Ribosome Interactions. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42347521 | PubMed |
| 42,297,998 | Integrating HTS and CRISPR/Cas for next-generation nucleic and non-nucleic acid diagnostics. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/42297998 | PubMed |
| 42,266,899 | Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates. | Chem Sci | 2026 | https://conductscience.org/library/papers/42266899 | PubMed |
| 42,261,660 | A Highly Selective, Cell-Permeable Fluorescent Probe for Imaging Histone Deacetylase 6 in Live Cells. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42261660 | PubMed |
| 42,088,608 | Comparative analysis for optimal LSD1 inhibitors evaluation techniques: pros and cons. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42088608 | PubMed |
1 to 10 of 184
See all 184 cited byGenes40
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADORA2A | 135 | PubTator's text mining | https://conductscience.org/library/genes/135 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| AVP | 551 | PubTator's text mining | https://conductscience.org/library/genes/551 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| CD86 | 942 | PubTator's text mining | https://conductscience.org/library/genes/942 | NCBI Gene |
| CX3CL1 | 6,376 | PubTator's text mining | https://conductscience.org/library/genes/6376 | NCBI Gene |
1 to 10 of 40
See all 40 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20161833
GET https://conductscience.org/api/papers/v1/20161833/references?page=2